BNP Paribas’s Boston Scientific BSX Stock Holding History

BNP Paribas’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.77M	Sell	33,428 -12,501	-27%	-$679K	0.05%	145
2026 Q1	$3.49M	Sell	45,929 -22,823	-33%	-$1.83M	0.11%	114
2025 Q4	$6.58M	Sell	68,752 -25,362	-27%	-$2.49M	0.19%	82
2025 Q3	$9.43M	Sell	94,114 -18,141	-16%	-$1.88M	0.28%	64
2025 Q2	$12.2M	Buy	112,255 +74,104	+194%	+$7.5M	0.4%	46
2025 Q1	$12.3M	Buy	38,151 +4,395	+13%	+$443K	0.51%	46
2024 Q4	$3.02M	Buy	33,756 +251	+0.7%	+$22.1K	0.02%	100
2024 Q3	$2.81M	Buy	33,505 +18,299	+120%	+$1.44M	0.12%	88
2024 Q2	$1.17M	Buy	15,206 +8,287	+120%	+$607K	0.06%	131
2024 Q1	$474K	Buy	+6,919	New	+$445K	0.02%	205

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

BNP Paribas's BSX Position: Q2 2026 in Review

BNP Paribas reduced its Boston Scientific (BSX) stake by 27% in Q2 2026, selling an estimated $679K and leaving 33,428 shares worth $1.77M. The position accounts for 0.05% of the portfolio, ranked #145.

BNP Paribas first reported a position in BSX in Q1 2024 and has held it in 10 quarters since. The position peaked at $12.3M in Q1 2025. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

BNP Paribas held 33,428 shares of Boston Scientific worth $1.77M as of Q2 2026.
BNP Paribas sold 12,501 Boston Scientific shares in Q2 2026, an estimated $679K.
Boston Scientific made up 0.05% of BNP Paribas's portfolio in Q2 2026, its #145 holding.
BNP Paribas first reported a position in Boston Scientific in Q1 2024 and has held it in 10 quarters since.
BNP Paribas's Boston Scientific position peaked at $12.3M in Q1 2025.
1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on BNP Paribas's 13F filing for Q2 2026, filed 13 Aug 2026.